未登录

Z

Zefang Lu

national center for nanoscience and technology and chinese academy of sciences

H指数:9

被引数:872

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reprogrammed apoptotic platelets drive rapid hemostasis through phosphatidylserine and prostaglandin E2 signaling in preclinical models

重编程的凋亡血小板通过磷脂酰丝氨酸和前列腺素E2信号通路在临床前模型中驱动快速止血

Science Translational Medicine

IF14.6

2026-05-210

PRE

Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence

个性化3D疫苗整合免疫疗法和抗血管生成疗法以预防口腔鳞状细胞癌复发

Advanced Materials

IF26.8

2025-07-240

PRE

The dynamic role of platelets in cancer progression and their therapeutic implications

NATURE REVIEWS CANCER

IF66.8

2023-12-0131

PRE

Monitoring circulating platelet activity to predict cancer-associated thrombosis

CELL REPORTS METHODS

IF4.5

2023-07-014

OAAI

Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer

CANCER RESEARCH

IF16.6

2023-06-166

PRE

Nanoparticle-based combination of LMWH and doxorubicin for the efficient treatment of hepatocellular carcinoma with portal vein tumor thrombus

IF10.9

2023-04-014

PRE

Identification of protein kinase C beta as a therapeutic target for neuroendocrine prostate cancer and development of a nanoparticle-based therapeutic strategy

IF10.9

2023-02-013

PRE

Reducing Postoperative Recurrence of Early-Stage Hepatocellular Carcinoma by a Wound-Targeted Nanodrug

通过伤口靶向纳米药物减少早期肝细胞癌的术后复发

ADVANCED SCIENCE

IF14.1

2022-05-0727

OA

Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction

ACTA PHARMACEUTICA SINICA B

IF14.6

2021-07-0113

OAAI

Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment

血小板膜包被的纳米颗粒使血管破坏剂结合抗血管生成药物可改善肿瘤血管损伤

IF9.1

2021-03-02101

PREAI

Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles

NATURE BIOMEDICAL ENGINEERING

IF26.6

2020-06-22115

PREAI

Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells

ACTA PHARMACOLOGICA SINICA

IF8.4

2020-05-2826

OAAI

Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models

在多种小鼠血栓形成模型中靶向递送纤溶酶原激活剂以逆转血栓的工程化纳米片

ADVANCED MATERIALS

IF26.8

2019-12-01157

PREAI